Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

EXENATIDE SYNTHETIC

EXENATIDE SYNTHETIC

Standard Dose
300MCG/1.2ML (250MCG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EXENATIDE SYNTHETIC is listed in Drugs@FDA under application 206697 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient EXENATIDE SYNTHETIC Form and strength INJECTABLE;SUBCUTANEOUS - 300MCG/1.2ML (250MCG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2024-11-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview EXENATIDE SYNTHETIC is listed in Drugs@FDA under application 206697 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EXENATIDE SYNTHETIC Form and strength INJECTABLE;SUBCUTANEOUS - 300MCG/1.2ML (250MCG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2024-11-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.